| Attribute |
Value |
| 52 Week Change |
-0.107241035 |
| Address1 |
1 Kenvue Way |
| All Time High |
27.795 |
| All Time Low |
14.02 |
| Ask |
0.0 |
| Ask Size |
16,700 |
| Audit Risk |
4 |
| Average Analyst Rating |
2.8 - Hold |
| Average Daily Volume10 Day |
17,972,540 |
| Average Daily Volume3 Month |
19,746,578 |
| Average Volume |
19,746,578 |
| Average Volume10Days |
17,972,540 |
| Beta |
0.437 |
| Bid |
0.0 |
| Bid Size |
8,800 |
| Board Risk |
3 |
| Book Value |
5.525 |
| City |
Summit |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
6 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
19.23 |
| Current Ratio |
0.983 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
19.865 |
| Day Low |
19.04 |
| Debt To Equity |
82.975 |
| Display Name |
Kenvue |
| Dividend Date |
1,779,840,000 |
| Dividend Rate |
0.83 |
| Dividend Yield |
4.32 |
| Earnings Call Timestamp End |
1,762,435,800 |
| Earnings Call Timestamp Start |
1,762,435,800 |
| Earnings Growth |
0.469 |
| Earnings Quarterly Growth |
0.472 |
| Earnings Timestamp |
1,778,157,000 |
| Earnings Timestamp End |
1,786,019,400 |
| Earnings Timestamp Start |
1,786,019,400 |
| Ebitda |
3,470,000,128 |
| Ebitda Margins |
0.22692 |
| Enterprise To Ebitda |
12.867 |
| Enterprise To Revenue |
2.92 |
| Enterprise Value |
44,648,767,488 |
| Eps Current Year |
1.18622 |
| Eps Forward |
1.24092 |
| Eps Trailing Twelve Months |
0.84 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,778,630,400 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
17.9798 |
| Fifty Day Average Change |
1.2502003 |
| Fifty Day Average Change Percent |
0.06953361 |
| Fifty Two Week Change Percent |
-10.724104 |
| Fifty Two Week High |
22.87 |
| Fifty Two Week High Change |
-3.6400013 |
| Fifty Two Week High Change Percent |
-0.15916052 |
| Fifty Two Week Low |
14.02 |
| Fifty Two Week Low Change |
5.209999 |
| Fifty Two Week Low Change Percent |
0.3716119 |
| Fifty Two Week Range |
14.02 - 22.87 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,683,207,000,000 |
| Float Shares |
1,917,455,056 |
| Forward Eps |
1.24092 |
| Forward P E |
15.496568 |
| Free Cashflow |
1,858,000,000 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
21,780 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.58599 |
| Gross Profits |
8,961,000,448 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00051 |
| Held Percent Institutions |
0.94786 |
| Implied Shares Outstanding |
1,920,008,668 |
| Industry |
Household & Personal Products |
| Industry Disp |
Household & Personal Products |
| Industry Key |
household-personal-products |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,778,630,400 |
| Last Dividend Value |
0.208 |
| Last Fiscal Year End |
1,766,880,000 |
| Long Business Summary |
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey. |
| Long Name |
Kenvue Inc. |
| Market |
us_market |
| Market Cap |
36,921,765,888 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_1820759186 |
| Most Recent Quarter |
1,774,742,400 |
| Net Income To Common |
1,622,000,000 |
| Next Fiscal Year End |
1,798,416,000 |
| Non Diluted Market Cap |
36,921,766,685 |
| Number Of Analyst Opinions |
12 |
| Open |
19.48 |
| Operating Cashflow |
2,257,999,872 |
| Operating Margins |
0.21617001 |
| Overall Risk |
5 |
| Payout Ratio |
0.98510003 |
| Peg Ratio |
1.6 |
| Phone |
908 874 1200 |
| Pre Market Change |
-0.23500061 |
| Pre Market Change Percent |
-1.2210995 |
| Pre Market Price |
19.01 |
| Pre Market Time |
1,784,020,125 |
| Previous Close |
19.48 |
| Price Eps Current Year |
16.211157 |
| Price Hint |
2 |
| Price To Book |
3.480543 |
| Price To Sales Trailing12 Months |
2.4144497 |
| Profit Margins |
0.106070004 |
| Quick Ratio |
0.607 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
hold |
| Recommendation Mean |
2.78571 |
| Region |
US |
| Regular Market Change |
-0.25 |
| Regular Market Change Percent |
-1.28337 |
| Regular Market Day High |
19.865 |
| Regular Market Day Low |
19.04 |
| Regular Market Day Range |
19.04 - 19.865 |
| Regular Market Open |
19.48 |
| Regular Market Previous Close |
19.48 |
| Regular Market Price |
19.23 |
| Regular Market Time |
1,783,972,802 |
| Regular Market Volume |
34,973,504 |
| Return On Assets |
0.07072 |
| Return On Equity |
0.15701 |
| Revenue Growth |
0.045 |
| Revenue Per Share |
7.973 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Consumer Defensive |
| Sector Disp |
Consumer Defensive |
| Sector Key |
consumer-defensive |
| Share Holder Rights Risk |
7 |
| Shares Outstanding |
1,920,008,668 |
| Shares Percent Shares Out |
0.0305 |
| Shares Short |
58,643,142 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
69,699,111 |
| Short Name |
Kenvue Inc. |
| Short Percent Of Float |
0.0354 |
| Short Ratio |
2.64 |
| Source Interval |
15 |
| State |
NJ |
| Symbol |
KVUE |
| Target High Price |
23.0 |
| Target Low Price |
18.0 |
| Target Mean Price |
19.58333 |
| Target Median Price |
19.0 |
| Total Cash |
1,075,000,064 |
| Total Cash Per Share |
0.56 |
| Total Debt |
8,801,999,872 |
| Total Revenue |
15,292,000,256 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.828 |
| Trailing Annual Dividend Yield |
0.042505134 |
| Trailing Eps |
0.84 |
| Trailing P E |
22.892857 |
| Trailing Peg Ratio |
1.6133 |
| Triggerable |
1 |
| Two Hundred Day Average |
17.30415 |
| Two Hundred Day Average Change |
1.9258499 |
| Two Hundred Day Average Change Percent |
0.111294106 |
| Type Disp |
Equity |
| Volume |
34,973,504 |
| Website |
https://www.kenvue.com |
| Zip |
7,901 |